HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Banking On Beauty Devices, 'Rapid' Anti-Aging For Consumer Growth

This article was originally published in The Rose Sheet

Executive Summary

During an investor day conference held May 18, Johnson & Johnson execs discussed the firm's consumer business at length, offering a preview of dynamic new launches planned for the year.

You may also be interested in...



J&J Recalls Neutrogena Light Therapy Acne Mask On Reports Of Eye Injuries

According to the J&J brand, a small subset of users with underlying eye conditions are potentially at risk of being injured by the FDA-cleared device, which uses red and blue LEDs to combat bacteria and inflammation associated with acne.

Neutrogena Debuts iPhone Scanner, App For Personalized Skin Analysis

The J&J brand gave attendees of the Consumer Electronics Show in Las Vegas a sneak peek of its iPhone-attachable SkinScanner and Skin360 app, which cooperate to provide users with scores on pores, lines/wrinkles and moisture levels, which then inform skin-care regimen recommendations.

NAD: Firm's Laser Cap Hair-Regrowth Claims Not Supported, Despite FDA Clearance

The Capillus82 Hair Regrowth Laser Cap may be "substantially equivalent" to the manufacturer's Capillus272 Pro device, based on FDA's 510(k) clearance, but NAD says hair-growth clinical findings from that "predicate" device cannot serve to substantiate claims for the untested Capillus82. The case illustrates complexities in the medical device segment, which increasingly is of interest to cosmetics companies.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS019921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel